Diabetes and the occurrence of infection in primary care: a matched cohort study

BMC Infectious Diseases

Table 4 Odds Ratio (OR) Between Diabetes and Infection Over the Full Follow-up Period: Crude and Adjusted Results

Type of Infection	Crude OR	95%CI	P value	Adjusted OR	95%CI	P value
Any Infection	0.96	0.86–1.06	0.399	1.21	1.07–1.37	0.002
Head & Neck	0.90	0.74–1.11	0.328	1.13	0.89–1.43	0.313
Respiratory	0.84	0.75–0.94	0.003	1.30	1.13–1.48	< 0.001
Gastrointestinal	1.38	1.15–1.67	< 0.001	1.40	1.12–1.75	0.003
Genitourinary	1.10	0.94–1.29	0.238	1.48	1.22–1.81	< 0.001
Skin & Soft Tissue	1.43	1.21–1.69	< 0.001	1.66	1.37–2.02	< 0.001
Musculoskeletal	0.97	0.82–1.14	0.714	1.05	0.87–1.28	0.598
Viral	1.21	0.95–1.55	0.115	1.15	0.86–1.54	0.351

Adjusted for age, sex, smoking, comorbidities (microvascular disease [nephropathy, neuropathy, retinopathy], macrovascular disease [coronary artery disease, peripheral and cerebral vascular disease], heart failure, respiratory disease, dyslipidemia, fatty liver disease, and obesity), medications (acid inhibitors, respiratory system medications, anti-lipids and vaccines) and number of infections in the year prior to enrollment

ISSN: 1471-2334